Reston, Virginia, May 15, 2012 – Aptiv Solutions, a biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today the appointment of Luis T. Gutierrez, Jr. as Executive Vice President and Chief Commercial Officer.  In this role, he will oversee the global Business Development, Proposal Development, … continue reading

Adaptive Design & Simulation Software for Population Enrichment Trials Reston, Virginia, April 17, 2012 – Aptiv Solutions, a biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today the latest release in its proprietary suite of adaptive trial software:  ADDPLAN® 6.0 PE. This groundbreaking software was … continue reading

Reston, Virginia, February 28, 2012 – Aptiv Solutions, a global biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today a collaboration with Tessella, a world leader in the provision of science powered technology and consulting services, to deliver integrated early phase adaptive design and execution … continue reading

Reston, Virginia, February 21, 2012 – Aptiv Solutions, a biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today several key appointments and promotions to strengthen the Company’s focus and leadership in providing adaptive clinical trial services. Corey Dunham has been promoted to Senior Vice President … continue reading

Reston, Virginia, February 14, 2012 – Aptiv Solutions, a biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today the launch of AptivAdvantageTM – a unique integrated technology platform for the implementation and execution of adaptive clinical trials. “Over the last six months we have seen … continue reading

Enhances Leadership within Adaptive Clinical Trials and Global Regulatory Reston, Virginia, December 1, 2011 – Aptiv Solutions, a biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation, and execution, announced today the appointment of key internal executives to global management roles.  Dr. Phil Birch has been named to the … continue reading

Expands Core Clinical Trial Services & Regulatory Consulting Reston, Virginia, October 3, 2011 – Aptiv Solutions, the leader in designing and executing adaptive clinical trials and medical device studies, announced it has acquired SRA Global Clinical Development (GCD), the CRO division of SRA International, Inc. based in Durham, N.C., with offices in Paris, France and … continue reading

Reston, Virginia, September 28, 2011 – Aptiv Solutions, a leader in designing and executing adaptive clinical trials, announced it has been selected to manage a major breast cancer clinical vaccine program for Galena Biopharma, a biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Galena’s key … continue reading

 Acquires Medical Device Consultants, Inc. Reston, Virginia, August 22, 2011 – Aptiv Solutions announced today the acquisition of Medical Device Consultants, Inc. (MDCI), a provider of expert medical device consulting and clinical trial management and execution. Aptiv Solutions is one of the leading providers of clinical trial management services to the medical device industry. This … continue reading

Two Companies Team to Bring Adaptive Clinical Trial Design to Life Science Companies Reston, Virginia, June 20, 2011 – Two industry leaders will jointly drive advanced clinical trial design and deployment of adaptive clinical trials. An agreement between Aptiv Solutions, a leader in designing and executing adaptive clinical trials, and SAS, the leader in Business … continue reading